Beno[C][1,2,5]oxadiazole for the treatment of diseases caused by Helicobacter

The present invention relates to new compounds which are benzo[c][1,2,5]oxadiazole derivatives, and the use thereof in the treatment of infectious diseases caused by Helicobacter pylori. Also, the present invention relates to a pharmaceutical composition and to a combined preparation both comprising said compounds
Universidad de Zaragoza, Consejo Superior de Investigaciones Científicas (España), Fundación Instituto de Investigación Sanitaria de Aragón, Fundación Agencia Aragonesa para la Investigación y el Desarrollo, Instituto Pasteur
A1 Solicitud de patente con informe sobre el estado de la técnica